There is currently no treatment for restoring lost neurological function after stroke. A growing number of studies have highlighted the potential of stem cells. However, the mechanisms underlying their beneficial effect have yet to be explored in sufficient detail. In this study, we transplanted human induced pluripotent stem cell-derived neural precursors (iPSC-NPs) in rat temporary middle cerebral artery occlusion (MCAO) model. Using magnetic resonance imaging (MRI) and magnetic resonance spectroscopy (MRS) we monitored the effect of cells and assessed lesion volume and metabolite changes in the brain. We monitored concentration changes of myo-inositol (Ins), Taurine (Tau), Glycerophosphocholine+Phosphocholine (GPC+PCh), N-acetyl-aspartate+N-acetyl-aspartyl-glutamate (NAA+NAAG), Creatine+Phosphocreatine (Cr+PCr), and Glutamate+Glutamine (Glu+Gln) in the brains of control and iPSC-NP-transplanted rats. Based on initial lesion size, animals were divided into small lesion and big lesion groups. In the small lesion control group (SCL), lesion size after 4 months was three times smaller than initial measurements. In the small lesion iPSC-NP-treated group, lesion volume decreased after 1 month and then increased after 4 months. Although animals with small lesions significantly improved their motor skills after iPSC-NP transplantation, animals with big lesions showed no improvement. However, our MRI data demonstrate that in the big lesion iPSC-NP-treated (BTL) group, lesion size increased only up until 1 month after MCAO induction and then decreased. In contrast, in the big lesion control group, lesion size increased throughout the whole experiment. Significantly higher concentrations of Ins, Tau, GPC+PCh, NAA+NAAG, Cr+PCr, and Glu+Gln were found in in contralateral hemisphere in BTL animals 4 months after cell injection. Lesion volume decreased at this time point. Spectroscopic results of metabolite concentrations in lesion correlated with volumetric measurements of lesion, with the highest negative correlation observed for NAA+NAAG. Altogether, our results suggest that iPSC-NP transplantation decreases lesion volume and regulates metabolite concentrations within the normal range expected in healthy tissue. Further research into the ability of iPSC-NPs to differentiate into tissue-specific neurons and its effect on the long-term restoration of lesioned tissue is necessary.

1st Faculty of Medicine Institute of Biophysics and Informatics Charles University Prague Czechia

Department of Neuroregeneration Institute of Experimental Medicine Czech Academy of Sciences Prague Czechia

Department of Neuroscience 2nd Faculty of Medicine Charles University Prague Czechia

Department of Neuroscience Institute of Experimental Medicine Czech Academy of Sciences Prague Czechia

Faculty of Health Studies Technical University of Liberec Liberec Czechia

MR Unit Department of Diagnostic and Interventional Radiology Institute for Clinical and Experimental Medicine Prague Czechia

Zobrazit více v PubMed

Bushnell CD. Stroke in women: risk and prevention throughout the lifespan. Neurol Clin. (2008) 26, 1161–76, xi. 10.1016/j.ncl.2008.05.009 PubMed DOI PMC

Darsalia V, Kallur T, Kokaia Z. Survival, migration and neuronal differentiation of human fetal striatal and cortical neural stem cells grafted in stroke-damaged rat striatum. Eur J Neurosci. (2007) 26:605–14. 10.1111/j.1460-9568.2007.05702.x PubMed DOI

Takahashi K, Yasuhara T, Shingo T, Muraoka K, Kameda M, Takeuchi A, et al. . Embryonic neural stem cells transplanted in middle cerebral artery occlusion model of rats demonstrated potent therapeutic effects, compared to adult neural stem cells. Brain Res. (2008) 1234:172–82. 10.1016/j.brainres.2008.07.086 PubMed DOI

Honmou O, Onodera R, Sasaki M, Waxman SG, Kocsis JD. Mesenchymal stem cells: therapeutic outlook for stroke. Trends Mol Med. (2012) 18:292–7. 10.1016/j.molmed.2012.02.003 PubMed DOI

Huang W, Mo X, Qin C, Zheng J, Liang Z, Zhang C. Transplantation of differentiated bone marrow stromal cells promotes motor functional recovery in rats with stroke. Neurol Res. (2013) 35:320–8. 10.1179/1743132812Y.0000000151 PubMed DOI

Oki K, Tatarishvili J, Wood J, Koch P, Wattananit S, Mine Y, et al. . Human-induced pluripotent stem cells form functional neurons and improve recovery after grafting in stroke-damaged brain. Stem Cells. (2012) 30:1120–33. 10.1002/stem.1104 PubMed DOI

Tatarishvili J, Oki K, Monni E, Koch P, Memanishvili T, Buga AM, et al. . Human induced pluripotent stem cells improve recovery in stroke-injured aged rats. Restor Neurol Neurosci. (2014) 32:547–58. 10.3233/RNN-140404 PubMed DOI

Qin J, Ma X, Qi H, Song B, Wang Y, Wen X, et al. . Transplantation of induced pluripotent stem cells alleviates cerebral inflammation and neural damage in hemorrhagic stroke. PLoS ONE. (2015) 10:e0129881. 10.1371/journal.pone.0129881 PubMed DOI PMC

Baker EW, Platt SR, Lau VW, Grace HE, Holmes SP, Wang L, et al. . Induced pluripotent stem cell-derived neural stem cell therapy enhances recovery in an ischemic stroke pig model. Sci Rep. (2017) 7:10075. 10.1038/s41598-017-10406-x PubMed DOI PMC

Tornero D, Wattananit S, Gronning Madsen M, Koch P, Wood J, Tatarishvili J, et al. . Human induced pluripotent stem cell-derived cortical neurons integrate in stroke-injured cortex and improve functional recovery. Brain. (2013) 136(Pt 12):3561–77. 10.1093/brain/awt278 PubMed DOI

Chau MJ, Deveau TC, Song M, Gu X, Chen D, Wei L. iPSC Transplantation increases regeneration and functional recovery after ischemic stroke in neonatal rats. Stem Cells. (2014) 32:3075–87. 10.1002/stem.1802 PubMed DOI

Birken DL, Oldendorf WH. N-acetyl-L-aspartic acid: a literature review of a compound prominent in 1H-NMR spectroscopic studies of brain. Neurosci Biobehav Rev. (1989) 13:23–31. 10.1016/S0149-7634(89)80048-X PubMed DOI

Simmons ML, Frondoza CG, Coyle JT. Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience. (1991) 45:37–45. 10.1016/0306-4522(91)90101-S PubMed DOI

Bruhn H, Frahm J, Gyngell ML, Merboldt KD, Hanicke W, Sauter R. Cerebral metabolism in man after acute stroke: new observations using localized proton NMR spectroscopy. Magn Reson Med. (1989) 9:126–31. 10.1002/mrm.1910090115 PubMed DOI

Weber R, Ramos-Cabrer P, Hoehn M. Present status of magnetic resonance imaging and spectroscopy in animal stroke models. J Cereb Blood Flow Metab. (2006) 26:591–604. 10.1038/sj.jcbfm.9600241 PubMed DOI

Polentes J, Jendelova P, Cailleret M, Braun H, Romanyuk N, Tropel P, et al. . Human induced pluripotent stem cells improve stroke outcome and reduce secondary degeneration in the recipient brain. Cell Transplant. (2012) 21:2587–602. 10.3727/096368912X653228 PubMed DOI

Wang H, Li Y, Jiang N, Chen X, Zhang Y, Zhang K, et al. . Protective effect of oxysophoridine on cerebral ischemia/reperfusion injury in mice. Neural Regen Res. (2013) 8:1349–59. 10.3969/j.issn.1673-5374.2013.15.001 PubMed DOI PMC

Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. . Induced pluripotent stem cell lines derived from human somatic cells. Science. (2007) 318:1917–20. 10.1126/science.1151526 PubMed DOI

Arvidsson A, Kirik D, Lundberg C, Mandel RJ, Andsberg G, Kokaia Z, et al. . Elevated GDNF levels following viral vector-mediated gene transfer can increase neuronal death after stroke in rats. Neurobiol Dis. (2003) 14:542–56. 10.1016/j.nbd.2003.08.002 PubMed DOI

Provencher SW. Estimation of metabolite concentrations from localized in vivo proton NMR spectra. Magn Reson Med. (1993) 30:672–9. 10.1002/mrm.1910300604 PubMed DOI

Rumpel H, Lim WE, Chang HM, Chan LL, Ho GL, Wong MC, et al. . Is myo-inositol a measure of glial swelling after stroke? A magnetic resonance study. J Magn Reson Imaging. (2003) 17:11–9. 10.1002/jmri.10233 PubMed DOI

Yu W, Ye C, Greenberg ML. Inositol hexakisphosphate kinase 1. (IP6K1) regulates inositol synthesis in mammalian cells. J Biol Chem. (2016) 291:10437–44. 10.1074/jbc.M116.714816 PubMed DOI PMC

Govindaraju V, Young K, Maudsley AA. Proton NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. (2000) 28:923–24. 10.1002/1099-1492(200005)13:3<129::AID-NBM619>3.0.CO;2-V PubMed DOI

Kumari N, Prentice H, Wu JY. Taurine and its neuroprotective role. Adv Exp Med Biol. (2013) 775:19–27. 10.1007/978-1-4614-6130-2_2 PubMed DOI

Menzie J, Prentice H, Wu JY. Neuroprotective mechanisms of taurine against ischemic stroke. Brain Sci. (2013) 3:877–907. 10.3390/brainsci3020877 PubMed DOI PMC

Bustillo JR, Jones T, Chen H, Lemke N, Abbott C, Qualls C, et al. . Glutamatergic and neuronal dysfunction in gray and white matter: a spectroscopic imaging study in a large schizophrenia sample. Schizophr Bull. (2017) 43:611–19. 10.1093/schbul/sbw122 PubMed DOI PMC

Pomares FB, Funck T, Feier NA, Roy S, Daigle-Martel A, Ceko M, et al. . Histological underpinnings of grey matter changes in fibromyalgia investigated using multimodal brain imaging. J Neurosci. (2017) 37:1090–101. 10.1523/JNEUROSCI.2619-16.2016 PubMed DOI PMC

Smith RN, Agharkar AS, Gonzales EB. A review of creatine supplementation in age-related diseases: more than a supplement for athletes. F1000Res. (2014) 3:222. 10.12688/f1000research.5218.1 PubMed DOI PMC

Campos F, Sobrino T, Ramos-Cabrer P, Argibay B, Agulla J, Pérez-Mato M, et al. . Neuroprotection by glutamate oxaloacetate transaminase in ischemic stroke: an experimental study. J Cereb Blood Flow Metab. (2011) 31:1378–86. 10.1038/jcbfm.2011.3 PubMed DOI PMC

Jeitner TM, Battaile K, Cooper AJ. Critical evaluation of the changes in glutamine synthetase activity in models of cerebral stroke. Neurochem Res. (2015) 40:2544–56. 10.1007/s11064-015-1667-1 PubMed DOI

Schneider CA, Rasband WS, Eliceiri KW. NIH Image to ImageJ: 25 years of image analysis. Nature Methods. (2012) 9:671–5. 10.1038/nmeth.2089 PubMed DOI PMC

Romanyuk N, Amemori T, Turnovcova K, Prochazka P, Onteniente B, Sykova E, et al. . Beneficial effect of human induced pluripotent stem cell-derived neural precursors in spinal cord injury repair. Cell Transplant. (2015) 24:1781–97. 10.3727/096368914X684042 PubMed DOI

Forster D, Davies K, Williams S. Magnetic resonance spectroscopy in vivo of neurochemicals in a transgenic model of Alzheimer's disease: a longitudinal study of metabolites, relaxation time, and behavioral analysis in TASTPM and wild-type mice. Magn Reson Med. (2013) 69:944–55. 10.1002/mrm.24349 PubMed DOI

Hanna J, Wernig M, Markoulaki S, Sun CW, Meissner A, Cassady JP, et al. . Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science. (2007) 318:1920–3. 10.1126/science.1152092 PubMed DOI

Dimos JT, Rodolfa KT, Niakan KK, Weisenthal LM, Mitsumoto H, Chung W, et al. . Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science. (2008) 321:1218–21. 10.1126/science.1158799 PubMed DOI

Karakikes I, Ameen M, Termglinchan V, Wu JC. Human induced pluripotent stem cell-derived cardiomyocytes: insights into molecular, cellular, and functional phenotypes. Circ Res. (2015) 117:80–8. 10.1161/CIRCRESAHA.117.305365 PubMed DOI PMC

Shahjalal HM, Abdal Dayem A, Lim KM, Jeon TI, Cho SG. Generation of pancreatic beta cells for treatment of diabetes: advances and challenges. Stem Cell Res Therapy. (2018) 9:355. 10.1186/s13287-018-1099-3 PubMed DOI PMC

Anderson TR, Jarvis CR, Biedermann AJ, Molnar C, Andrew RD. Blocking the anoxic depolarization protects without functional compromise following simulated stroke in cortical brain slices. J Neurophysiol. (2005) 93:963–79. 10.1152/jn.00654.2004 PubMed DOI

Ghandforoush-Sattari M, Mashayekhi SO, Nemati M, Ayromlou H. Changes in plasma concentration of taurine in stroke. Neurosci Lett. (2011) 496:172–5. 10.1016/j.neulet.2011.04.010 PubMed DOI

Xing C, Arai K, Lo EH, Hommel M. Pathophysiologic cascades in ischemic stroke. Int J Stroke. (2012) 7:378–85. 10.1111/j.1747-4949.2012.00839.x PubMed DOI PMC

Saunders DE. MR spectroscopy in stroke. Br Med Bull. (2000) 56:334–45. 10.1258/0007142001903256 PubMed DOI

Jadavji NM, Emmerson JT, MacFarlane AJ, Willmore WG, Smith PD. B-vitamin and choline supplementation increases neuroplasticity and recovery after stroke. Neurobiol Dis. (2017) 103:89–100. 10.1016/j.nbd.2017.04.001 PubMed DOI

Prass K, Royl G, Lindauer U, Freyer D, Megow D, Dirnagl U, et al. . Improved reperfusion and neuroprotection by creatine in a mouse model of stroke. J Cereb Blood Flow Metab. (2007) 27:452–9. 10.1038/sj.jcbfm.9600351 PubMed DOI

McCabe C, Arroja MM, Reid E, Macrae IM. Animal models of ischaemic stroke and characterisation of the ischaemic penumbra. Neuropharmacology. (2018) 134(Pt B):169–77. 10.1016/j.neuropharm.2017.09.022 PubMed DOI

Pfeuffer J, Tkac I, Provencher SW, Gruetter R. Toward an in vivo neurochemical profile: quantification of 18 metabolites in short-echo-time. (1)H NMR spectra of the rat brain. J Magn Reson. (1999) 141:104–20. 10.1006/jmre.1999.1895 PubMed DOI

Petroff OA, Ogino T, Alger JR. High-resolution proton magnetic resonance spectroscopy of rabbit brain: regional metabolite levels and postmortem changes. J Neurochem. (1988) 51:163–71. 10.1111/j.1471-4159.1988.tb04850.x PubMed DOI

de Graaf RA, Brown PB, McIntyre S, Nixon TW, Behar KL, Rothman DL. High magnetic field water and metabolite proton T1 and T2 relaxation in rat brain in vivo. Magn Reson Med. (2006) 56:386–94. 10.1002/mrm.20946 PubMed DOI

Kettunen MI, Gröhn OH, Kauppinen RA. Quantitative T1 NMR spectroscopy of rat cerebral metabolites in vivo: effects of global ischemia. Magn Reson Med. (2004) 51:875–80. 10.1002/mrm.20099 PubMed DOI

Expandable Sendai-Virus-Reprogrammed Human iPSC-Neuronal Precursors: In Vivo Post-Grafting Safety Characterization in Rats and Adult Pig

Transplantation of Neural Precursors Derived from Induced Pluripotent Cells Preserve Perineuronal Nets and Stimulate Neural Plasticity in ALS Rats